Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veliparib and Combination Chemotherapy in Advanced Head and Neck Cancer
NCT01711541Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2012
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of veliparib in head and neck squamous cell carcinoma (HNSCC), sponsored by National Cancer Institute. Started Oct 2012; status: completed.
02
Drugs
veliparib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01711541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711541.